Go beyond the classically considered androgenic hormones. This review describes some of the non-steroidal PEDs of abuse that may present to the emergency department setting and potential challenges in
Released in October 2019, CRASH-3 is the latest trial exploring the benefits of tranexamic acid, this time in traumatic brain injury. The bottom line: TXA hasn't been shown to reduce mortality.